|
|
Name: |
PERCEPTIVE ADVISORS LLC |
City: |
WASHINGTON |
State: |
DC |
Zip: |
20015 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
28 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
CERE |
Cerevel Therapeutics Holdin... |
1 |
- |
$42.47 |
$464,924,000 |
10,965,193 |
10.39% |
244,695,000 |
876,808 |
7.015 |
N/A |
|
FOLD |
Amicus Therapeutics Inc |
2 |
- |
$10.61 |
$398,135,000 |
28,057,456 |
8.9% |
61,389,000 |
364,539 |
8.247 |
Biotechnology |
|
ACLX |
Arcellx, Inc. |
4 |
- |
$0.00 |
$252,237,000 |
4,544,809 |
5.64% |
109,938,000 |
578,831 |
9.28 |
N/A |
|
NUVL |
Nuvalent, Inc. |
5 |
- |
$0.00 |
$214,735,000 |
2,917,991 |
4.8% |
101,490,000 |
454,540 |
4.437 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
8 |
- |
$38.28 |
$99,024,000 |
2,154,110 |
2.21% |
90,294,000 |
1,773,282 |
3.037 |
N/A |
|
IOVA |
Iovance Biotherapeutics Inc |
10 |
- |
$11.64 |
$97,393,000 |
11,979,415 |
2.18% |
42,962,000 |
16,477 |
5.601 |
N/A |
|
AXSM |
Axsome Therapeutics, Inc. |
12 |
- |
$71.71 |
$82,616,000 |
1,038,019 |
1.85% |
48,954,000 |
556,370 |
2.194 |
N/A |
|
MDT |
Medtronic Plc |
13 |
- |
$79.74 |
$80,457,000 |
976,652 |
1.8% |
34,460,000 |
389,652 |
0.073 |
Medical Appliances & ... |
|
BHVN |
Biohaven Ltd. |
17 |
- |
$38.97 |
$73,832,000 |
1,725,047 |
1.65% |
54,277,000 |
973,227 |
2.15 |
N/A |
|
SWTX |
Springworks Therapeutics, Inc. |
18 |
- |
$0.00 |
$71,439,000 |
1,957,246 |
1.6% |
36,287,000 |
436,830 |
2.469 |
N/A |
|
IRON |
Disc Medicine, Inc |
22 |
- |
$27.55 |
$59,091,000 |
1,023,045 |
1.32% |
17,014,000 |
127,404 |
4.238 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
23 |
- |
$0.60 |
$56,096,000 |
2,606,679 |
1.25% |
55,102,000 |
2,525,563 |
4.261 |
N/A |
|
NTRA |
Natera, Inc. |
24 |
- |
$91.66 |
$53,258,000 |
850,225 |
1.19% |
43,604,000 |
632,047 |
0.742 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
25 |
- |
$8.10 |
$53,178,000 |
2,139,950 |
1.19% |
21,257,000 |
219,292 |
5.927 |
N/A |
|
VRCA |
Verrica Pharmaceuticals Inc. |
26 |
- |
$6.87 |
$51,966,000 |
7,099,182 |
1.16% |
32,390,000 |
2,060,199 |
27.623 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
27 |
- |
$21.98 |
$51,171,000 |
1,707,398 |
1.14% |
20,078,000 |
189,931 |
1.844 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
29 |
- |
$0.00 |
$50,700,000 |
1,100,748 |
1.13% |
29,606,000 |
483,248 |
1.462 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
31 |
- |
$0.00 |
$45,469,000 |
2,003,058 |
1.02% |
28,232,000 |
870,567 |
3.895 |
N/A |
|
SRPT |
Sarepta Therapeutics Inc |
33 |
- |
$128.77 |
$43,574,000 |
451,873 |
0.97% |
21,425,000 |
269,153 |
0.537 |
Drug Manufacturers - ... |
|
EOLS |
Evolus Inc |
34 |
- |
$11.43 |
$41,735,000 |
3,963,424 |
0.93% |
28,155,000 |
2,477,623 |
6.862 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
35 |
- |
$12.88 |
$37,684,000 |
1,730,212 |
0.84% |
22,172,000 |
719,007 |
2.759 |
N/A |
|
NAUT |
Nautilus Biotechnology, Inc |
36 |
- |
$2.49 |
$37,657,000 |
12,594,211 |
0.84% |
8,866,000 |
3,483,060 |
10.153 |
N/A |
|
NBIX |
Neurocrine Biosciences Inc |
39 |
- |
$135.99 |
$35,680,000 |
270,794 |
0.8% |
17,765,000 |
111,552 |
0.29 |
Biotechnology |
|
MDGL |
Madrigal Pharmaceuticals Inc |
40 |
- |
$193.33 |
$34,973,000 |
151,151 |
0.78% |
16,771,000 |
26,514 |
0.766 |
Diagnostic Substances |
|
ATXS |
Astria Therapeutics, Inc |
41 |
- |
$9.00 |
$30,751,000 |
4,004,070 |
0.69% |
14,418,000 |
1,814,608 |
7.324 |
N/A |
|
ATHA |
Athira Pharma, Inc. |
61 |
- |
$0.00 |
$13,129,000 |
5,402,964 |
0.29% |
3,438,000 |
605,686 |
17.531 |
N/A |
|
ITCI |
Intra Cellular Therapies Inc |
67 |
- |
$73.26 |
$7,735,000 |
108,000 |
0.17% |
7,735,000 |
108,000 |
0.114 |
N/A |
|
VERU |
Veru Inc |
79 |
- |
$1.27 |
$4,021,000 |
5,584,699 |
0.09% |
3,237,000 |
4,494,821 |
7.994 |
Personal Products |
|